株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

癌胎児性抗原検査市場の分析・規模・シェア・動向・予測 (2020-2026年) :性別・エンドユーザー・地域

Carcinoembryonic Antigen Testing Market, By Application, By Gender, By End User and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026

発行 AnalystView Market Insights 商品コード 943547
出版日 ページ情報 英文 206 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
癌胎児性抗原検査市場の分析・規模・シェア・動向・予測 (2020-2026年) :性別・エンドユーザー・地域 Carcinoembryonic Antigen Testing Market, By Application, By Gender, By End User and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
出版日: 2020年06月01日 ページ情報: 英文 206 Pages
概要

癌胎児性抗原 (CEA) 検査市場規模は、2019年までに23億6000万米ドルとなり、2020~2026年の予測期間中はCAGR6.4%で成長する見込みです。癌の有病率の増加、一人当たりの医療費の増加、および低侵襲診断手法に対する需要の増加は、 世界の癌胎児性抗原市場の成長を後押しする主要な要因です。さらに、癌などの慢性内科疾患になりやすい高齢者人口の急増は、市場の成長を後押しする可能性があります。世界保健機関(WHO)によると、2018年には世界全体の人口の約4380万人が癌を患っていました。さらに、ラジオイムノアッセイなどの新しい免疫学的手法の絶え間ない開発と投入により、予測期間中は市場全体に有利な成長機会が生まれると予測されています。しかし、CEA検査に関連する副作用と感染のリスクは、今後の市場の成長を妨げると予想されます。

当レポートでは、世界の癌胎児性抗原 (CEA) 検査市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

第1章 癌胎児性抗原 (CEA) 検査市場の概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 市場内訳:試験タイプ別
    • 市場内訳:アプリケーション別
    • 市場内訳:性別
    • 市場内訳:エンドユーザー別
    • 市場内訳:地域別
  • 競合考察

第3章 癌胎児性抗原 (CEA) 検査の主な市場動向

  • 市場成長促進要因
    • 市場成長要因の影響分析
  • 市場成長抑制要因
    • 市場成長抑制要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 癌胎児性抗原 (CEA) 検査業界の調査

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析
  • COVID-19影響分析
    • COVID-19以前の影響分析
    • COVID-19以降の影響分析

第5章 癌胎児性抗原 (CEA) 検査市場の情勢

  • 市場シェア分析
  • 主要イノベーター
  • 分析データ:主要メーカー別
    • 既存企業分析
    • 新興企業分析

第6章 癌胎児性抗原 (CEA) 検査市場:検査タイプ別

  • 概要
  • 酵素結合免疫測定法(EIA)
  • ラジオイムノアッセイ(RIA)
  • 電気化学発光免疫測定法(ECLIA)
  • その他

第7章 癌胎児性抗原 (CEA) 検査市場:アプリケーション別

  • 概要
  • 卵巣癌
  • 大腸癌
  • 膵臓癌
  • 乳癌
  • 肺癌
  • 前立腺癌
  • 甲状腺癌
  • その他

第8章 癌胎児性抗原 (CEA) 検査市場:性別

  • 概要
  • 男性
  • 女性

第9章 癌胎児性抗原 (CEA) 検査市場:エンドユーザー別

  • 概要
  • 病院
  • 研究ラボ
  • 診断センター
  • がんセンター
  • その他

第10章 癌胎児性抗原検査 (CEA) 市場:地域別

  • イントロダクション
    • セグメントシェア分析:地域別
  • 北米
    • 概要
    • 北米の主要メーカー
    • 北米の市場規模と予測:国別
    • 北米の市場規模と予測:検査タイプ別
    • 北米の市場規模と予測:アプリケーション別
    • 北米の市場規模と予測:エンドユーザー別
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • 欧州の市場規模と予測:国別
    • 欧州の市場規模と予測:検査タイプ別
    • 欧州の市場規模と予測:アプリケーション別
    • 欧州の市場規模と予測:エンドユーザー別
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • アジア太平洋の市場規模と予測:国別
    • アジア太平洋の市場規模と予測:検査タイプ別
    • アジア太平洋の市場規模と予測:アプリケーション別
    • アジア太平洋の市場規模と予測:エンドユーザー別
    • インド
    • 中国
    • 日本
    • 韓国
    • アジア太平洋のその他諸国
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ラテンアメリカの市場規模と予測:製品別
    • ラテンアメリカの市場規模と予測:検査タイプ別
    • ラテンアメリカの市場規模と予測:アプリケーション別
    • ラテンアメリカの市場規模と予測:エンドユーザー別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • 中東・アフリカの市場規模と予測:製品別
    • 中東・アフリカの市場規模と予測:検査タイプ別
    • 中東・アフリカの市場規模と予測:アプリケーション別
    • 中東・アフリカの市場規模と予測:エンドユーザー別
    • サウジアラビア
    • アラブ首長国連邦

第11章 主要ベンダーの分析

  • Omega Diagnostics Group
  • GenWay Biotech Inc.
  • Quest Diagnostics
  • Abbott Laboratories
  • Creative Diagnostics
  • Boster Biological Technology
  • Correlogic Systems, Inc.
  • Lee Biosolutions
  • RayBiotech
  • Amgen
  • Roche Diagnostics

第12章 アナリストの全方位的展望

第13章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Carcinoembryonic Antigen (CEA) Testing market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Application 2015-2026 (USD Million)
  • TABLE Carcinoembryonic Antigen (CEA) Testing market: Gender Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Gender
  • TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Gender 2015-2026 (USD Million)
  • TABLE Carcinoembryonic Antigen (CEA) Testing market: Testing Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Testing Type
  • TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Testing Type 2015-2026 (USD Million)
  • TABLE Carcinoembryonic Antigen (CEA) Testing market: End User Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by End User2015-2026 (USD Million)
  • TABLE Carcinoembryonic Antigen (CEA) Testing market: Regional Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Region 2015-2026 (USD Million)
  • TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
  • TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
  • TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
  • TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
  • TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
  • TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
  • TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
  • TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
  • TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)

TABLEAsia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)

  • TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
  • TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
  • TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
  • TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Distribtion Channel, 2015-2026 (USD Million)

List of Figures

  • FIGURE Carcinoembryonic Antigen (CEA) Testing market segmentation
  • FIGURE Market Research Methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Testing Type segment market share analysis, 2019 & 2026
  • FIGURE Testing Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Enzyme-Linked Immunoassay (EIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Radio-Immunoassay (RIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Electro-Chemiluminescence Immunoassay (ECLIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Ovarian Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Colorectal Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Pancreatic Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Breast Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Lung Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Prostate Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Thyroid Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Gender segment market share analysis, 2019 & 2026
  • FIGURE Gender segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Male market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Female market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End User segment market share analysis, 2019 & 2026
  • FIGURE End User segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Research Laboratories market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Diagnostic Centre market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cancer Centre market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
  • FIGURE Europe Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
  • FIGURE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
  • FIGURE Latin America Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
  • FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
  • FIGURE North America Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
  • FIGURE U.S. Carcinoembryonic Antigen (CEA) Testing Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Carcinoembryonic Antigen (CEA) Testing Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Carcinoembryonic Antigen (CEA) Testing Market share analysis by country, 2018
  • FIGURE Germany Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE FranceCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
  • FIGURE India Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APACCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin AmericaCarcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
  • FIGURE BrazilCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
  • FIGURE Saudi Arabia Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

Title:
Carcinoembryonic Antigen (CEA) Testing Market, By Application (Ovarian Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Thyroid Cancer), By Gender (Male and Female), By End User (Diagnostic Centre, Cancer Centre, Hospitals, and Research Laboratories) and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2020-2026.

Report Highlight

Carcinoembryonic antigen (CEA) testing market was valued at USD 2.36 billion by 2019, growing with 6.4% CAGR during the forecast period, 2020-2026.

Carcinoembryonic antigen or CEA is a group of glycoprotein present in the body fluids of the embryo, fetus, and gastrointestinal tract. CEA is normally found in the embryonic entodermal epithelium. CEA is also present in the mucosal cells of the gastrointestinal cells, colorectum, and small amounts in the blood. The gastrointestinal tissue produces carcinoembryonic antigen during the development of fetal. The CEA test is especially used for cancers of the large intestine and the rectum. It is one of the most commonly used tumor markers worldwide.

Market Dynamics

The increasing prevalence of cancer, rising per capita healthcare expenditure, and growing demand for minimally invasive diagnostic procedures are the major factors boosting the growth of the global carcinoembryonic antigen market. In addition, the rapidly rising geriatric population who are prone to chronic medical conditions such as cancer is likely to fuel market growth. According to the World Health Organization (WHO), around 43.8 million of the total world population was suffering from cancer in 2018. Furthermore, the constant development and introduction of novel immunological techniques, such as radioimmunoassay are predicted to create lucrative growth opportunities in the overall market during the forecast period. However, the side-effects and risk of infections associated with CEA testing are expected to hamper the market growth in the coming future.

Testing Types Takeaway

"Enzyme-Linked Immunoassay accounted for the highest revenue share"

CEA level in the human blood can be measure through various testing such as Electro-chemiluminescence immunoassay (ECLIA), enzyme-linked immunoassay (EIA), radio-immunoassay (RIA), and others. Though all the above-mentioned testing methods are used to quantify the CEA level, their sensitivity may vary. Among these, the EIA method is considered to be the most preferable clinical practice. This is because of the use of radioisotopes and thus, it offers effective and accurate diagnostic power.

Application Takeaway

"Colorectal segment to hold the largest market share during the forecast period"

Based on the application, the global carcinoembryonic antigen market is categorized into ovarian cancer, colorectal cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and thyroid cancer. Among these, the colorectal cancer segment subjugated the global market in 2019 and is estimated to hold the largest market share in terms of revenue during the forecast period. This is majorly owing to a surge in demand for minimally invasive diagnostic procedures, a growing prevalence of unhealthy lifestyles, and a rising geriatric population. In addition, unhealthy dietary habits and increasing consumption of alcohol are other factors contributing to the segmental market growth. On the other hand, the breast cancer segment is estimated to grow at the fastest rate during the period of forecast owing to the growing demand for cosmetic surgeries & hormone replacement therapy (HRT) and a rise in the number of female populations all over the world.

Gender Takeaway

"Male segment to account for the majority of market share by 2026"

On the basis of gender, the overall CEA market is bifurcated into male and female. Of these, the male segment accounted for the largest market share in 2019 owing to more prevalence of cancer in men as compared to women. According to the NIH's National Institute of Cancer, cancer prevalence is higher among men with 196.8 per 100,000 men. However, in women, it is 139.6 per 100,000 women. In addition, certain risk factors, such as drinking and smoking affect more to men than women. On the other hand, the female segment is anticipated to grow at a significant rate by the end of 2026 owing to the growing occurrences of breast cancer.

End-User Takeaway

"Hospitals segment to be most lucrative in the forecast period"

Based on end-user, the worldwide CEA market is categorized into hospitals, diagnostic, and cancer centers. and research laboratories. Among these, the hospital segment accounted for the majority of share in the market in 2019 and is expected to lead the worldwide market by 2026. This is primarily owing to the growing incidence of cancer all over the world. Besides, CEA tests in hospitals have various benefits such as staying connected to the healthcare system through IoT (Internet of Things), and improved diagnosis accuracy along with sophisticated healthcare infrastructure.

Regional Takeaway

"North America region to dominate the global industry until 2026"

Depending on the region, the global industry is divided into North America, Europe, Middle East & Africa, Asia Pacific, and Latin America. The North American market for CEA played a dominant role in 2019 and is expected to continue its dominance throughout the forecast. This is mainly attributed to the presence of well-established healthcare infrastructure, high occurrence rates of cancer, and higher expenditure levels.

Along with North America, the Asia Pacific region is expected to grow at a rapid pace in the global market during the period of forecast owing to constantly improving infrastructure for healthcare. Moreover, the economic development, presence of untapped opportunities, and increasing patient awareness levels are other factors expected to contribute to the regional market growth in the coming future. Also, this region has the highest mortality rate due to the high prevalence of cancer.

COVID-19 Impact

Adapting to the recent novel coronavirus crisis, the COVID-19 has progressively impacted the global carcinoembryonic antigen market. The thorough analysis of the COVID-19 pandemic on the overall market is included in the research report. The influence of the novel COVID-19 pandemic on the growth of the CEA market is analyzed and depicted in the research report.

Key Vendor Takeaway

The leading players operating in the global CEA market include Correlogic Systems, Inc., GenWay Biotech Inc., Omega Diagnostics Group, Creative Diagnostics, Boster Biological Technology, Quest Diagnostics, Abbott Laboratories, Lee Biosolutions, RayBiotech, Amgen, and Roche Diagnostics. Among these, Abbott was emerged as the leading players, accounted for the significant market share in 2019. The company's global presence coupled with a wide product portfolio has helped Abbott to capture a large customer base.

In addition, key players are actively involved in investing in R&D activities to develop new products. In October 2019, a biotechnology company, SurgiMab, announced that the first patient in the U.S. has been recruited for its on-going pivotal Phase 3 clinical trial for colorectal cancer surgery with the carcinoembryonic antigen test. This trail evaluates its investigational imaging agent namely, 'SGM-101' in cancer patients undergoing surgery.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

CARCINOEMBRYONIC ANTIGEN (CEA) MARKET KEY PLAYERS

Correlogic Systems, Inc.

GenWay Biotech Inc.

Omega Diagnostics Group

Creative Diagnostics

Boster Biological Technology

Quest Diagnostics

Abbott Laboratories

Lee Biosolutions

RayBiotech

Amgen

Roche Diagnostics

CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY TESTING TYPE

Enzyme-Linked Immunoassay (EIA)

Radio-Immunoassay (RIA)

Electro-Chemiluminescence Immunoassay (ECLIA)

Others

CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY APPLICATION

Ovarian Cancer

Colorectal Cancer

Pancreatic Cancer

Breast Cancer

Lung Cancer

Prostate Cancer

Thyroid Cancer

Others

CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY GENDER

Male

Female

CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY END USER

Diagnostic Centre

Cancer Centre

Hospitals

Research Laboratories

Others

CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Testing Type
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Gender
    • 2.1.4. Market Snippet by End User
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET - BY TESTING TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Testing Type, 2019 & 2026 (%)
  • 6.2. Enzyme Linked Immunoassay (EIA)
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Radio-Immunoassay (RIA)
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Electro-Chemiluminescence Immunoassay (ECLIA)
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Others
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET - BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 7.2. Ovarian Cancer
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Colorectal Cancer
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Pancreatic Cancer
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Breast Cancer
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.6. Lung Cancer
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.7. Prostate Cancer
    • 7.7.1. Overview
    • 7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.8. Thyroid Cancer
    • 7.8.1. Overview
    • 7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.9. Others
    • 7.9.1. Overview
    • 7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET - BY GENDER

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 8.2. Male
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Female
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET - BY END USER

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2019 & 2026 (%)
  • 9.2. Hospitals
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Research Laboratories
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Diagnostic Centre
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Cancer Centre
    • 9.5.1. Overview
    • 9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Others
    • 9.6.1. Overview
    • 9.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Testing Type, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Testing Type, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Testing Type, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Testing Type, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Testing Type, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Omega Diagnostics Group
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Application Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. GenWay Biotech Inc.
  • 11.3. Quest Diagnostics
  • 11.4. Abbott Laboratories
  • 11.5. Creative Diagnostics
  • 11.6. Boster Biological Technology
  • 11.7. Correlogic Systems, Inc.
  • 11.8. Lee Biosolutions
  • 11.9. RayBiotech
  • 11.10. Amgen
  • 11.11. Roche Diagnostics

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us